| Literature DB >> 20856718 |
Robert L Comis1, Jon D Miller, Diane D Colaizzi, Linda G Kimmel.
Abstract
The development of new cancer therapies requires additional, and more complex, clinical trials. But only approximately 3% to 5% of adult cancer patients participate in cancer clinical trials. This study seeks to identify and understand the attitudes of the public and cancer survivors toward health-related decisions and cancer clinical trials to identify the key factors that must be addressed to increase that percentage.Entities:
Year: 2009 PMID: 20856718 PMCID: PMC2790653 DOI: 10.1200/JOP.0922001
Source DB: PubMed Journal: J Oncol Pract ISSN: 1554-7477 Impact factor: 3.840